Table 5.
Baseline Characteristics of Patients Who Completed ≥12 Versus <12 Weeks on Study
| Pts with ≥12W on study (n = 310) | Pts who dropped out <12W (n = 169) | |
|---|---|---|
| Treatment arm | ||
| Experimental | 158 (51.0%) | 82 (48.5%) |
| Control | 152 (49.0%) | 87 (51.5%) |
| Age | 60.7 (11) | 60.4 (12) |
| Gender | ||
| Female | 183 (59.0%) | 89 (52.7%) |
| Male | 127 (41.0%) | 80 (47.3%) |
| Race/ethnicity | ||
| African American | 20 (6.5%) | 14 (8.3%) |
| Asian | 30 (9.7%) | 16 (9.5%) |
| Caucasian | 210 (67.7%) | 122 (72.2%) |
| Hispanic Latino | 32 (10.3%) | 11 (6.5%) |
| Native Hawaiian | 5 (1.6%) | 1 (0.6%) |
| Mixed race | 9 (2.9%) | 3 (1.8%) |
| Other | 4 (1.3%) | 2 (1.2%) |
| Education, N (%) | ||
| Did not complete high school | 4 (1.3%) | 3 (1.8%) |
| High school | 67 (21.6%) | 42 (24.9%) |
| College | 178 (57.4%) | 80 (47.3%) |
| Graduate/professional school | 53 (17.1%) | 43 (25.4%) |
| No response | 8 (2.6%) | 1 (0.6%) |
| Religion, N (%) | ||
| None | 56 (18.1%) | 23 (13.6%) |
| Protestant | 121 (39.0%) | 65 (38.5%) |
| Catholic | 92 (29.7%) | 49 (29.0%) |
| Jewish | 16 (5.2%) | 12 (7.1%) |
| Other or no response | 25 (1.9%) | 20 (2.4%) |
| Marital status, N (%) | ||
| Never married | 9 (2.9%) | 12 (7.1%) |
| Married/living with partner | 223 (71.9%) | 136 (80.5%) |
| Divorced/separated | 51 (16.5%) | 13 (7.7%) |
| Widowed | 24 (7.7%) | 8 (4.7%) |
| No response | 3 (1.0%) | 0 (0.0%) |
| Other members, N (%) | ||
| None (lives alone) | 42 (13.5%) | 17 (10.1%) |
| Spouse | 132 (42.6%) | 81 (47.9%) |
| Children | 21 (6.8%) | 4 (2.4%) |
| Friend | 15 (4.8%) | 7 (4.1%) |
| Multiple relatives/friends | 97 (31.3%) | 60 (35.5%) |
| No response | 3 (1.0%) | 0 (0.0%) |
| Employment status, N (%) | ||
| Employed full time | 68 (21.9%) | 46 (27.2%) |
| Employed part time | 37 (11.9%) | 17 (10.1%) |
| Homemaker | 20 (6.5%) | 13 (7.7%) |
| Retired | 126 (40.6%) | 65 (38.5%) |
| Unemployed/student | 53 (17.1%) | 27 (16.0%) |
| No response | 6 (2.0%) | 1 (0.6%) |
| Family income, N (%) | ||
| $10,000 or less | 4 (1.3%) | 3 (1.8%) |
| $10,001 to $20,000 | 6 (1.9%) | 4 (2.4%) |
| $20,001 to $30,000 | 13 (4.2%) | 4 (2.4%) |
| $30,001 to $40,000 | 14 (4.5%) | 13 (7.7%) |
| $40,001 to $50,000 | 70 (22.6%) | 28 (16.6%) |
| Greater than $50,000 | 184 (59.4%) | 105 (62.1%) |
| No response | 19 (6.1%) | 12 (7.1%) |
| Type of cancer,*N (%) | ||
| Bladder | 11 (3.5%) | 2 (1.2%) |
| Breast | 25 (8.1%) | 13 (7.7%) |
| Cervical | 7 (2.3%) | 2 (1.2%) |
| Colon | 47 (15.2%) | 33 (19.5%) |
| Lung | 52 (16.8%) | 21 (12.4%) |
| Ovarian | 27 (8.7%) | 15 (8.9%) |
| Pancreatic | 13 (4.2%) | 29 (17.2%) |
| Prostate | 17 (5.5%) | 4 (2.4%) |
| Rectal | 18 (5.8%) | 10 (5.9%) |
| Other | 93 (30.0%) | 40 (23.7%) |
| Current and previous surgical procedure, N (%) | ||
| Yes | 233 (75.2%) | 112 (66.3%) |
| No | 74 (23.9%) | 53 (31.4%) |
| No response | 3 (1.0%) | 4 (0.2%) |
| Current and previous chemotherapy, N (%) | ||
| Yes | 264 (85.2%) | 158 (93.5%) |
| No | 42 (13.5%) | 9 (5.3%) |
| No response | 4 (1.3%) | 2 (0.1%) |
| Current and previous radiation therapy, N (%) | ||
| Yes | 141 (45.5%) | 71 (42.0%) |
| No | 158 (51.0%) | 91 (53.8%) |
| No response | 11 (3.5%) | 7 (4.1%) |
| Tried alternative therapies, N (%) | ||
| Yes | 63 (20.3%) | 57 (33.7%) |
| No | 235 (75.8%) | 108 (63.9%) |
| No response | 12 (3.9%) | 4 (0.2%) |
| Number of comorbidities | 1.8 (1.5) | 1.5 (1.3) |
*
Statistically significant difference between groups (p < 0.05), with Fisher's exact test.